Skip to content
Recall Observatory FDA recall evidence

Device product

Leccurate SARS-CoV-2, Antigen Rapid Test Kit (Colloidal Gold Immunochromatography), 1 test, IVD. for the qualitative detection of antigen SARS-CoV-2 in clinical samples (nasal swab).

Z-1620-2021

April 26, 2021

Class I

Product summary

Firm
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD
Event
Event 87737
Status
Completed
Classification
Class I
Quantity
8, 419, 545 units in total
Official record key
device-enforcement:Z-1620-2021

Official wording

Reason: Antigen Rapid Test Kit is not authorized, cleared, or approved for marketing and/or distribution in the U.S.

Code information: All Lots distributed within the U.S.

Distribution pattern: Worldwide Distribution: US Distribution to states of: FL, IL, NY, GA, Puerto Rico and OUS countries of: Canada, Honduras, Peru, Dominican, Bolivia, Colombia, Mexico, Brazil, Argentina, Guatemala, Venezuela, Ecuador, Chile, Paraguay, Panama, Costa Rica, Peru and Hong Kong.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Antigen Rapid Test Kit is not authorized, cleared, or approved for marketing and/or distribution in the U.S.